Publication
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
| dc.contributor.author | Pereira da Silva, JA | |
| dc.contributor.author | Jacobs, JW | |
| dc.contributor.author | Kirwan, JR | |
| dc.contributor.author | Boers, M | |
| dc.contributor.author | Saag, KG | |
| dc.contributor.author | Inês, L | |
| dc.contributor.author | Koning, EJ | |
| dc.date.accessioned | 2008-11-27T16:01:30Z | |
| dc.date.available | 2008-11-27T16:01:30Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo. | en |
| dc.identifier.citation | Ann Rheum Dis. 2006 Mar;65(3):285-93. | en |
| dc.identifier.uri | http://hdl.handle.net/10400.4/204 | |
| dc.language.iso | eng | en |
| dc.subject | Artrite Reumatóide | en |
| dc.subject | Glucocorticóides | en |
| dc.subject | Medicina Baseada na Evidência | en |
| dc.subject | Anti-Reumáticos | en |
| dc.title | Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data | en |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | |
| rcaap.type | article | en |